KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 145 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $829,000 | -10.2% | 11,058 | -9.8% | 0.00% | 0.0% |
| Q2 2015 | $923,000 | +78.5% | 12,254 | +18.8% | 0.00% | +100.0% |
| Q1 2015 | $517,000 | +44.4% | 10,313 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $358,000 | +5.9% | 10,313 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $338,000 | -14.6% | 10,313 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $396,000 | +17.5% | 10,313 | +21.5% | 0.00% | 0.0% |
| Q1 2014 | $337,000 | +6.6% | 8,486 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $316,000 | -18.6% | 8,486 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $388,000 | +68.7% | 8,486 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $230,000 | – | 8,486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 48,087 | $1,668,000 | 4.13% |
| Versant Venture Management, LLC | 70,376 | $2,440,640,000 | 2.33% |
| Palo Alto Investors LP | 1,121,884 | $38,907,000 | 2.28% |
| Aureus Asset Management, LLC | 124,087 | $4,303,000 | 1.05% |
| PFM Health Sciences, LP | 1,085,315 | $37,639,000 | 0.88% |
| HARBOURVEST PARTNERS LLC | 39,318 | $1,364,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,119,425,000 | 0.52% |
| Partner Investment Management, L.P. | 24,456 | $848,000 | 0.35% |
| Old West Investment Management, LLC | 15,162 | $525,000 | 0.32% |
| Polar Capital LLP | 405,544 | $14,063,000 | 0.27% |